The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Animal Blood Plasma and Derivatives-Global Market Insights and Sales Trends 2025
Synopsis
The global Animal Blood Plasma and Derivatives market size is expected to reach US$ 1403.5 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Blood Plasma and Derivatives in various end use industries. The expanding demands from the Food & Beverages, Pharmaceuticals, Cosmetics and Feed, are propelling Animal Blood Plasma and Derivatives market. Immunoglobulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fibrinogen segment is estimated at % CAGR for the next seven-year period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 220%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Blood Plasma and Derivatives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Blood Plasma and Derivatives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Blood Plasma and Derivatives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Blood Plasma and Derivatives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Blood Plasma and Derivatives covered in this report include Proliant Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Kraeber & Co GmbH, LAMPIRE Biological Laboratories, Inc., Lake Immunogenics, Inc., Rocky Mountain Biologicals Inc., ANZCO Foods Ltd. and Auckland BioSciences Ltd., etc.
The global Animal Blood Plasma and Derivatives market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
Global Animal Blood Plasma and Derivatives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Blood Plasma and Derivatives market, Segment by Type:
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Global Animal Blood Plasma and Derivatives market, by Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animal Blood Plasma and Derivatives companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Animal Blood Plasma and Derivatives market size is expected to reach US$ 1403.5 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Blood Plasma and Derivatives in various end use industries. The expanding demands from the Food & Beverages, Pharmaceuticals, Cosmetics and Feed, are propelling Animal Blood Plasma and Derivatives market. Immunoglobulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fibrinogen segment is estimated at % CAGR for the next seven-year period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 220%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Blood Plasma and Derivatives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Blood Plasma and Derivatives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Blood Plasma and Derivatives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Blood Plasma and Derivatives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Blood Plasma and Derivatives covered in this report include Proliant Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Kraeber & Co GmbH, LAMPIRE Biological Laboratories, Inc., Lake Immunogenics, Inc., Rocky Mountain Biologicals Inc., ANZCO Foods Ltd. and Auckland BioSciences Ltd., etc.
The global Animal Blood Plasma and Derivatives market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
Global Animal Blood Plasma and Derivatives market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Blood Plasma and Derivatives market, Segment by Type:
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Global Animal Blood Plasma and Derivatives market, by Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animal Blood Plasma and Derivatives companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Animal Blood Plasma and Derivatives
1.1 Animal Blood Plasma and Derivatives Market Overview
1.1.1 Animal Blood Plasma and Derivatives Product Scope
1.1.2 Animal Blood Plasma and Derivatives Market Status and Outlook
1.2 Global Animal Blood Plasma and Derivatives Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Animal Blood Plasma and Derivatives Market Size by Region (2018-2029)
1.4 Global Animal Blood Plasma and Derivatives Historic Market Size by Region (2018-2023)
1.5 Global Animal Blood Plasma and Derivatives Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Animal Blood Plasma and Derivatives Market Size (2018-2029)
1.6.1 North America Animal Blood Plasma and Derivatives Market Size (2018-2029)
1.6.2 Europe Animal Blood Plasma and Derivatives Market Size (2018-2029)
1.6.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size (2018-2029)
1.6.4 Latin America Animal Blood Plasma and Derivatives Market Size (2018-2029)
1.6.5 Middle East & Africa Animal Blood Plasma and Derivatives Market Size (2018-2029)
2 Animal Blood Plasma and Derivatives Market by Type
2.1 Introduction
2.1.1 Immunoglobulin
2.1.2 Fibrinogen
2.1.3 Serum Albumin
2.1.4 Fetal Bovine Serum
2.1.5 Thrombin
2.1.6 New Born Calf Serum
2.2 Global Animal Blood Plasma and Derivatives Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Type (2018-2023)
2.2.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Animal Blood Plasma and Derivatives Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Animal Blood Plasma and Derivatives Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Animal Blood Plasma and Derivatives Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Animal Blood Plasma and Derivatives Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Animal Blood Plasma and Derivatives Revenue Breakdown by Type (2018-2029)
3 Animal Blood Plasma and Derivatives Market Overview by Application
3.1 Introduction
3.1.1 Food & Beverages
3.1.2 Pharmaceuticals
3.1.3 Cosmetics
3.1.4 Feed
3.1.5 Others
3.2 Global Animal Blood Plasma and Derivatives Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Application (2018-2023)
3.2.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Animal Blood Plasma and Derivatives Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Animal Blood Plasma and Derivatives Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Animal Blood Plasma and Derivatives Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Animal Blood Plasma and Derivatives Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Animal Blood Plasma and Derivatives Revenue Breakdown by Application (2018-2029)
4 Animal Blood Plasma and Derivatives Competition Analysis by Players
4.1 Global Animal Blood Plasma and Derivatives Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2022)
4.3 Date of Key Players Enter into Animal Blood Plasma and Derivatives Market
4.4 Global Top Players Animal Blood Plasma and Derivatives Headquarters and Area Served
4.5 Key Players Animal Blood Plasma and Derivatives Product Solution and Service
4.6 Competitive Status
4.6.1 Animal Blood Plasma and Derivatives Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Proliant Inc.
5.1.1 Proliant Inc. Profile
5.1.2 Proliant Inc. Main Business
5.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Products, Services and Solutions
5.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.1.5 Proliant Inc. Recent Developments
5.2 Thermo Fisher Scientific, Inc.
5.2.1 Thermo Fisher Scientific, Inc. Profile
5.2.2 Thermo Fisher Scientific, Inc. Main Business
5.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Products, Services and Solutions
5.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific, Inc. Recent Developments
5.3 Merck KGaA
5.3.1 Merck KGaA Profile
5.3.2 Merck KGaA Main Business
5.3.3 Merck KGaA Animal Blood Plasma and Derivatives Products, Services and Solutions
5.3.4 Merck KGaA Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.3.5 Kraeber & Co GmbH Recent Developments
5.4 Kraeber & Co GmbH
5.4.1 Kraeber & Co GmbH Profile
5.4.2 Kraeber & Co GmbH Main Business
5.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Products, Services and Solutions
5.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.4.5 Kraeber & Co GmbH Recent Developments
5.5 LAMPIRE Biological Laboratories, Inc.
5.5.1 LAMPIRE Biological Laboratories, Inc. Profile
5.5.2 LAMPIRE Biological Laboratories, Inc. Main Business
5.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Products, Services and Solutions
5.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.5.5 LAMPIRE Biological Laboratories, Inc. Recent Developments
5.6 Lake Immunogenics, Inc.
5.6.1 Lake Immunogenics, Inc. Profile
5.6.2 Lake Immunogenics, Inc. Main Business
5.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Products, Services and Solutions
5.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.6.5 Lake Immunogenics, Inc. Recent Developments
5.7 Rocky Mountain Biologicals Inc.
5.7.1 Rocky Mountain Biologicals Inc. Profile
5.7.2 Rocky Mountain Biologicals Inc. Main Business
5.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Products, Services and Solutions
5.7.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.7.5 Rocky Mountain Biologicals Inc. Recent Developments
5.8 ANZCO Foods Ltd.
5.8.1 ANZCO Foods Ltd. Profile
5.8.2 ANZCO Foods Ltd. Main Business
5.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Products, Services and Solutions
5.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.8.5 ANZCO Foods Ltd. Recent Developments
5.9 Auckland BioSciences Ltd.
5.9.1 Auckland BioSciences Ltd. Profile
5.9.2 Auckland BioSciences Ltd. Main Business
5.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Products, Services and Solutions
5.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.9.5 Auckland BioSciences Ltd. Recent Developments
5.10 Bovogen Biologicals Pty Ltd.
5.10.1 Bovogen Biologicals Pty Ltd. Profile
5.10.2 Bovogen Biologicals Pty Ltd. Main Business
5.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Products, Services and Solutions
5.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue (US$ Million) & (2018-2023)
5.10.5 Bovogen Biologicals Pty Ltd. Recent Developments
6 North America
6.1 North America Animal Blood Plasma and Derivatives Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Animal Blood Plasma and Derivatives Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Animal Blood Plasma and Derivatives Market Dynamics
11.1 Animal Blood Plasma and Derivatives Industry Trends
11.2 Animal Blood Plasma and Derivatives Market Drivers
11.3 Animal Blood Plasma and Derivatives Market Challenges
11.4 Animal Blood Plasma and Derivatives Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
